EUNSOOK KIM: Open Payments
NPI 1295464469 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$170 in 8 payments from 6 companies in 2025. Trend: 2023 $15 · 2024 $62 · 2025 $170
Food & beverage: $170
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 2 | $54 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $24 |
| Bausch Health US, LLC | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
Products named: FANAPT, REXULTI, Kerendia, APLENZIN, UZEDY, TRINTELLIX.
Industry payments across CA — which companies pay providers there.
